Medication Switching to Test for Primary Aldosteronism
Download: Medication Switching Guide
Primary aldosteronism is suspected in hypertensive patients when plasma aldosterone is normal or high in the setting of a low or suppressed renin concentration, which gives rise to an elevated aldosterone to renin ratio (ARR). However, many antihypertensive medications can affect aldosterone and renin levels.
To help you prepare your patients for the optimal diagnosis of primary aldosteronism, the Endocrine Hypertension group at Monash Health / Hudson Institute of Medical Research has produced a clinician and patient information sheet to help you prepare your patients for the optimal diagnosis of primary aldosteronism.
If you have any feedback, please email A/Prof Jun Yang (jun.yang@hudson.org.au).
Endocrine Society of Australia
145 Macquarie Street
Sydney. NSW. 2000
Email: ijohnson@endocrinesociety.org.au
The Endocrine Society of Australia acknowledges the Australian Aboriginal and Torres Strait Islander peoples as the first inhabitants of the nation and the traditional custodians of the lands where we live, learn and work. We pay our respects to their Elders past, present and emerging.
